Literature DB >> 33539936

Integrating rapid diagnostics in Gram-negative bloodstream infections of patients colonized by carbapenemase-producing Enterobacterales.

G Bianco1, M Boattini2, M Iannaccone2, L Pastrone2, A Bondi2, M Peradotto2, R Cavallo2, C Costa2.   

Abstract

We implemented a fast-track diagnostic approach for Gram-negative bloodstram infections (BSIs) among carbapenemase-producing Enterobacterales (CPE) carriers. Within a large cohort of patients with CPE rectal carriage, 18.1% developed Gram-negative BSIs, of which 69.5% were caused by CPE. Direct matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis provided reliable identification in 97% and 53.8% of monomicrobical blood cultures positive to Enterobacterales and non-fermenting Gram-negative species, respectively. Overall, sensitivity and specificity of NG-Test Carba 5 compared with the composite reference method after discrepant analysis were 100%, in polimicrobial blood cultures too. The combined use of direct MALDI-TOF MS and NG-Test Carba 5 assay might be a reliable and cost-effective tool for accelerating the laboratory diagnosis of CPE BSI in cohorts of high-risk patients such as CPE carriers.
Copyright © 2021 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bloodstream infection; Carbapenemase producing Enterobacterales; MALDI-TOF MS; Rapid diagnostics; Rectal carriage; Surveillance screening

Mesh:

Substances:

Year:  2021        PMID: 33539936     DOI: 10.1016/j.jhin.2021.01.015

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  1 in total

1.  Implementation of Chromatic Super CAZ/AVI® medium for active surveillance of ceftazidime-avibactam resistance: preventing the loop from becoming a spiral.

Authors:  Gabriele Bianco; Matteo Boattini; Sara Comini; Alessio Leone; Alessandro Bondi; Teresa Zaccaria; Rossana Cavallo; Cristina Costa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-08-06       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.